{"id":"https://openalex.org/W1985283047","doi":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","title":"Abstract SY10-02: Breast cancer subtypes have selective kinome reprogramming in response to kinase inhibitors.","display_name":"Abstract SY10-02: Breast cancer subtypes have selective kinome reprogramming in response to kinase inhibitors.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W1985283047","doi":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","mag":"1985283047"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-sy10-02","doi":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gary Johnson","raw_affiliation_strings":["University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5047612906"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"SY10","last_page":"02"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.07760000228881836,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-subtypes","display_name":"breast cancer subtypes","score":0.9850000143051147},{"id":"https://openalex.org/keywords/kinome-reprogramming","display_name":"kinome reprogramming","score":0.9860000014305115},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/inhibitor-resistance","display_name":"inhibitor resistance","score":0.7120000123977661},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/luminal-breast-cancer","display_name":"luminal breast cancer","score":0.8029999732971191},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/basal-like-breast-cancer","display_name":"basal-like breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/claudin-low-breast-cancer","display_name":"claudin-low breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.9983266592025757},{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.8215391635894775},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6080304980278015},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5288114547729492},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5058321952819824},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4800878167152405},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4367362856864929},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.21508660912513733},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.20855757594108582},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10804963111877441},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10746711492538452}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-sy10-02","doi":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-sy10-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415020828","https://openalex.org/W2601359557","https://openalex.org/W2165575701","https://openalex.org/W2029695051","https://openalex.org/W2623615300","https://openalex.org/W2316336219","https://openalex.org/W2044043190","https://openalex.org/W2294495954","https://openalex.org/W2026352397","https://openalex.org/W2403873152"],"abstract_inverted_index":{"Abstract":[0],"Multiplexed":[1],"Inhibitor":[2],"Beads":[3],"coupled":[4],"with":[5,97],"quantitative":[6],"Mass":[7],"Spectrometry":[8],"(MIB/MS)":[9],"allows":[10],"study":[11],"of":[12,15,39,116,145,150],"over":[13],"60-70%":[14],"the":[16,65,146,151],"expressed":[17],"kinome":[18,47,66,101,109,135],"simultaneously":[19],"using":[20],"lysates":[21],"from":[22],"cell":[23],"lines,":[24],"mouse":[25],"tumors":[26,32],"and":[27,36,62],"human":[28],"specimens.":[29],"Cells":[30],"or":[31,41],"are":[33,71],"assessed":[34],"before":[35],"after":[37],"addition":[38],"agonists":[40],"inhibitors.":[42,141],"Results":[43],"show":[44],"a":[45],"systems":[46],"reprogramming":[48,102,136],"in":[49,64,82,95,103,123,137],"response":[50,83,104,138],"to":[51,84,105,120,139],"highly":[52,85],"selective":[53,134],"inhibitors":[54,90],"that":[55],"creates":[56],"inhibitor":[57],"resistance.":[58],"The":[59],"activation":[60,67],"signatures":[61],"changes":[63],"profile":[68],"(kinome":[69],"reprogramming)":[70],"unique":[72],"for":[73,113,154],"each":[74],"breast":[75],"cancer":[76,122,131],"subtype":[77],"(Luminal,":[78],"HER2+,":[79],"Basal-like,":[80],"Claudin-low)":[81],"selective,":[86],"clinically":[87],"relevant":[88],"kinase":[89,140],"(MEKinh,":[91],"mTOR/PI3Kinh).":[92],"Window":[93],"trials":[94],"patients":[96],"TNBC":[98],"have":[99,133],"shown":[100],"MEKinh,":[106],"suggesting":[107],"understanding":[108],"resiliency":[110],"is":[111],"necessary":[112],"rational":[114],"design":[115],"effective":[117],"combination":[118],"therapies":[119],"treat":[121],"individual":[124],"patients.":[125],"Citation":[126],"Format:":[127],"Gary":[128],"Johnson.":[129],"Breast":[130],"subtypes":[132],"[abstract].":[142],"In:":[143],"Proceedings":[144],"104th":[147],"Annual":[148],"Meeting":[149],"American":[152],"Association":[153],"Cancer":[155,165],"Research;":[156],"2013":[157],"Apr":[158],"6-10;":[159],"Washington,":[160],"DC.":[161],"Philadelphia":[162],"(PA):":[163],"AACR;":[164],"Res":[166],"2013;73(8":[167],"Suppl):Abstract":[168],"nr":[169],"SY10-02.":[170],"doi:10.1158/1538-7445.AM2013-SY10-02":[171]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}